The Food and Drug Administration’s recommendations apply to pulse oximeters, which are clip-on devices used in hospitals and medical clinics to ensure patients are getting enough oxygen.

Makers of medical devices that quickly measure oxygen levels in the blood would have to gather extra data to show that their products work for patients of color.